WORLD'S LARGEST MARKET RESEARCH RESOURCE — 1,519,265 REPORTS

 
 
• SEARCH FOR A REPORT

Viewing report

Search
Enter keywords, a title or a report id number below.
Advanced

• ORDER BY FAX

Order By Fax

• SELECT SITE CURRENCY

Select a currency for use throughout the site



  • Electronic (PDF) Information Icon
  • Site License Information Icon
  • Enterprisewide Information Icon
Live Chat Live Help Software for Website

Cardiac Science Corporation (CSCX) - Financial and Strategic SWOT Analysis Review

GlobalData, December 2010, Pages: 38

Cardiac Science Corporation (CSCX) - Financial and Strategic SWOT Analysis Review

Summary

Cardiac Science Corporation (Cardiac Science) is engaged in the development, manufacture and marketing of diagnostic as well as therapeutic cardiology products and services. It provides an array of cardiology products designed to identify the early stages of heart disease, including electrocardiographs, cardiac stress testing systems, and holter monitors. The company operates in Europe, Asia, and the Americas. Cardiac Science markets its products in more than 100 countries worldwide.

Cardiac Science Corporation Key Recent Developments

Nov 09, 2010 Cardiac Science Reports Total Revenues Of $34.48 Million For Q3 2010
Oct 19, 2010 Howard G. Smith Investigates Proposed Acquisition Of Cardiac Science By OCI
Jul 29, 2010 Cardiac Science Reports Revenues Of $36.10 Million In Q2 2010
Jul 27, 2010 Cardiac Science Unveils Two New Cardiac Stress Systems
Jul 19, 2010 Cardiac Science Addresses FDA Recall Concerns

This comprehensive SWOT profile of Cardiac Science Corporation provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note-: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
-The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.



List of Tables
List of Figures
Section 1 - About the Company
Cardiac Science Corporation - Key Facts
Cardiac Science Corporation - Key Employees
Cardiac Science Corporation - Key Employee Biographies
Cardiac Science Corporation - Major Products and Services
Cardiac Science Corporation - History
Cardiac Science Corporation - Company Statement
Cardiac Science Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Cardiac Science Corporation - Key Manufacturing Facilities
Section 2 – Company Analysis
Cardiac Science Corporation - Business Description
Business Description - Cardiac Monitoring Products
Cardiac Monitoring Products - Overview
Cardiac Monitoring Products - Financials
Cardiac Monitoring Products - Market View
Cardiac Monitoring Products - Key Strategies
Cardiac Monitoring Products - Technology
Business Description - Defibrillation Products
Defibrillation Products - Overview
Defibrillation Products - Financials
Defibrillation Products - Market View
Defibrillation Products - Key Strategies
Defibrillation Products - Technology
Business Description - Services
Services - Overview
Services - Financials
Cardiac Science Corporation - SWOT Analysis
SWOT Analysis - Overview
Cardiac Science Corporation - Strengths
Strength - Strong Brand Image
Strength - Innovation and Product Development
Strength - Broad Range of Cardiology Products
Cardiac Science Corporation - Weaknesses
Weakness - Over-dependence on the US Market
Weakness - Declining Market Share in the Sector
Weakness - Weak Cost Management
Weakness - Principal Manufacturing Facility
Cardiac Science Corporation - Opportunities
Opportunity - Strategic Partnerships
Opportunity - Increasing Cardiovascular Diseases
Opportunity - New Product Launches
Opportunity - Under-penetrated and Emerging Market Segments
Cardiac Science Corporation - Threats
Threat - Intense Competition
Threat - Cost Containment Pressures
Threat - FDA Recalls Concerns
Threat - Stringent Government Regulations
Cardiac Science Corporation - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Recent Developments
Nov 09, 2010: Cardiac Science Reports Total Revenues Of $34.48 Million For Q3 2010
Oct 19, 2010: Howard G. Smith Investigates Proposed Acquisition Of Cardiac Science By OCI
Jul 29, 2010: Cardiac Science Reports Revenues Of $36.10 Million In Q2 2010
Jul 27, 2010: Cardiac Science Unveils Two New Cardiac Stress Systems
Jul 19, 2010: Cardiac Science Addresses FDA Recall Concerns
Jul 19, 2010: Cardiac Science Updates AED Customers Affected By November 2009 Recall
Jul 14, 2010: Cardiac Science Introduces Wireless Diagnostic Workstation
Apr 28, 2010: Cardiac Science Reports Revenues Of $33.1 Million In Q1 2010
Apr 27, 2010: FDA Warns Users About Faulty Components In 14 External Defibrillator Models
Feb 04, 2010: Cardiac Science Updates On AED
Section 5 – Appendix
Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer

Midmark Corporation
Medtronic, Inc.
Welch Allyn Inc.
Schiller AG
Spacelabs Healthcare, Inc.
ZOLL Medical Corporation
ScottCare Corporation
Philips Healthcare
Goodman Co., Ltd.
Ambu A/S
Celera Corporation

Customers who bought this item also bought